Notice No20221115-43Notice Date15 Nov 2022
CategoryCompany relatedSegmentEquity
SubjectListing of Equity Shares of Global Health Limited

 Trading Members of the Exchange are hereby informed that effective from Wednesday, November 16, 2022, the equity shares of Global Health Limited shall be listed and admitted to dealings on the Exchange in the list of 'B ' Group of Securities.          

Name of the company

Global Health Limited

Registered Office:

Medanta – Mediclinic, E-18,

Defence Colony, New Delhi,

Delhi 110 024, India

Tel :+91 124 483 4060

Email :

Website :

No. of Securities

26,81,84,882 Equity Shares Of Rs.2/- each fully paid up

Distinctive Number range

1 To 268184882

Scrip ID on BOLT System


Abbreviated Name on BOLT System


Scrip Code




Market Lot


Issue Price for the current Public issue

Rs. 336/- per share (Face Value of Rs. 2/- and premium of Rs. 334/-)

Date of Allotment in the public issue:

November 11, 2022

Pari Pasu


Financial Year


Lock in detail

As per Annexure I

Shareholding Pattern

As per Annexure II


a) Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form.


b) Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Wednesday, November 16, 2022. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips.



c)The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depositorys records



d) The Registrar to the issue as mentioned in the prospectus is given below


KFin Technologies Limited

(formerly known as KFin Technologies Private Limited)

Address: Selenium, Tower-B Plot 31 and 32, Financial District Nanakramguda, Serilingampally Hyderabad, Rangareddi 500 032 Telangana, India

Tel: +91 40 6716 2222



Investor Grievance E-mail:

Contact person: M Murali Krishna

SEBI Registration No.:  INR000000221


e) In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:

a) At the company:


Rahul Ranjan

Company Secretary and Compliance Officer



Medanta – Mediclinic, E-18,

Defence Colony, New Delhi,

Delhi 110 024, India

Tel :+91 124 483 4060

Email :

Website :

b) At the Exchange:

Mr. Raghavendra Bhat

Associate Manager


Tel.: (91) 022 2272 8915


Rupal Khandelwal

Assistant General Manager

Tuesday, November 14,2022

Annexure I.pdf
Annexure II.pdf